Neurology
Breakthroughs in neurology and neuromodulation are redefining how clinicians understand, treat, and manage complex neurological conditions. But advancing these technologies requires deep expertise, spanning intricate regulatory classifications, advanced imaging requirements, and long-term clinical follow-up.
Avania’s MedTech focus, proven experience, and global team of neurology specialists help innovators navigate these complexities with confidence. From early feasibility through post-market studies, our integrated approach reduces risk, accelerates timelines, and ensures the highest scientific and operational standards across every phase.
Navigating the Unique Challenges of
Neurology Device Development
Developing neurological and neuromodulation devices requires more than technical precision; it demands an understanding of the human nervous system, its variability, and the regulatory rigor that comes with innovation in this space.
Avania brings extensive experience across neuromodulation, neurostimulation, and neurodiagnostic technologies, helping sponsors anticipate obstacles before they arise. Our regulatory and clinical experts have guided clients through FDA Breakthrough Device Designation, PMA/IDE studies, and complex post-market programs, delivering clarity in a space where precision matters most.
Unparalleled Expertise:
Meet Our Neurology MedTech Veterans
Principal Consultant, Neuromodulation SME
Bryan Wilent, PhD
- Former President of the American Society of Neurophysiological Monitoring (ASNM)
- 20+ years of regulatory and clinical strategy experience across neurostimulation and electrophysiology
Senior Clinical Project Manager
Elizabeth Kane, PhD
- Recognized for operational leadership in neuromodulation and neurodiagnostic programs spanning PMA and post-market stages

The Avania Team Advantage
At Avania, every project is led by a team of MedTech veterans who combine deep therapeutic insight with operational excellence. Our subject matter experts are actively involved throughout your study, training teams, engaging site networks, and guiding risk management from start-up through follow-up.

Deep Therapeutic & Industry Insight
Avania’s neurology specialists are steeped in the indications they serve, drawing on decades of industry experience to anticipate challenges and streamline approvals. Many have held leadership roles within clinical, regulatory, and device engineering functions, bringing practical, real-world perspective to every study.

Consistent, Dedicated & Flexible Teams
Clients consistently cite our low staff turnover and collaborative approach as key differentiators. Each Avania project team functions as a true extension of your organization, providing responsive, professional, and flexible support tailored to your device and patient population.

Integrated Solutions for Neurology Innovation
Avania delivers end-to-end support for neurological device development, integrating regulatory, engineering, clinical, and market access expertise to streamline your path from concept to commercialization.
Strategic Consulting & Regulatory Pathways
Our regulatory specialists engage early, planning the most efficient route to approval and ensuring evidence generation aligns with FDA expectations.
- Familiar with OHT5 (Neurological & Physical Medicine Devices) and DHT5B (Division of Neuromodulation & Physical Medicine Devices)
- Experience with Q-Submissions, TAP Program, and Breakthrough Device pathways
- Hundreds of FDA interactions supporting neurology device sponsors
- Expertise in safety endpoints, stimulation parameters, and human factors design for EFS and IDE submissions
Clinical Development & Execution
Our operational teams deliver the rigor and responsiveness needed for complex neurology studies:
- Dedicated PM and Clinical Lead with senior executive governance and SME oversight
- Active monitoring and data visualization dashboards for real-time risk tracking
- Expertise integrating device data and external datasets into EDC systems
- Field clinical specialists available for device setup, reprogramming, and procedural support
- Established site network and partner investigators across key neurology centers worldwide
Our Track Record
Demonstrated Success in Neurology
Avania’s neurology and neuromodulation portfolio spans more than 100 projects across North America, Europe, and Asia–Pacific, supporting breakthrough devices through IDE, PMA, De Novo, and post-market phases. Our teams have guided sponsors through every step of the development lifecycle — from early feasibility to market launch and long-term registry follow-up — while helping them achieve FDA milestones such as Breakthrough Device Designation and PMA approval.
Therapeutic Experience Across Neurology
Our hands-on expertise extends across the full spectrum of neurological and neurovascular technologies, including:
- Personalized & Closed-Loop Neurotechnology – Deep brain, spinal cord, dorsal root ganglion, and responsive neurostimulation systems that sense and adapt therapy in real time
- Wearable & Non-Invasive Neuromodulation – Portable tVNS, tDCS/tACS, and TMS systems for migraine, pain, and movement disorders, including home-use and consumer-grade devices
- AI & Neuromorphic Integration – Studies combining adaptive algorithms and predictive analytics for next-generation neuromodulation and monitoring platforms
- Neurodiagnostics & Imaging-Based Tools – Development and validation of advanced electrophysiology, EEG, and imaging-assisted systems for earlier detection and personalized treatment
- Neurovascular & Interventional Therapies – Support for stroke, neurovascular occlusion, and cerebral flow restoration technologies through pivotal and post-market phases
Representative Clinical Experience
Avania has executed studies for technologies addressing:
- Drug-resistant epilepsy – Multi-site pivotal and long-term follow-up programs
- Migraine, cluster headache, and facial pain – Neurostimulation and air-puff systems for high-disability populations
- Chronic low-back pain – Neuromodulation combined with physical therapy and medical management
- Peripheral nerve repair – Surgical applications following upper-limb or spinal trauma
- Temperature modulation and hypothermia control – Intra-operative and post-surgical devices for neuroprotection
- Wearable biomarker platforms – Data-driven Parkinson’s disease monitoring and progression tracking
- Endoscopic and ablative procedures – Device-assisted therapies for spinal and cranial indications

Client
Successes
With more than 900 MedTech projects, 500+ regulatory submissions, and 25+ Breakthrough Device designations supported across Avania’s portfolio, sponsors can rely on a proven record of performance — driving complex neurology and neuromodulation technologies from concept to global patient impact.
“Collaborating with Avania has been exceptional because their team combines the operational excellence you’d expect of a medical device CRO with true scientific depth and a genuine appreciation of patient care. What has stood out to me most is their ability to support complex, first-in-human and high-innovation studies with both rigor and agility. Avania doesn’t just manage studies — they chart the best course for pioneering therapies to efficiently reach that regulatory approval and achieve that market success that they want and need, while maintaining the integrity that both clients and patients deserve.”
Bryan Wilent, PhD, DABNM, FASNM
CEO and Founder at Neuroexpertise
“Neuros Medical’s success in executing a highly complex IDE/PMA clinical trial — one involving an extraordinary volume and sophistication of clinical data — would not have been possible without the partnership of Avania Clinical. Their depth of expertise, particularly across clinical operations and biostatistics, was exceptional… …The leadership of their Biostatistics team, in particular, played a critical role in our ultimate PMA approval… …I recommend Avania Clinical without reservation. Their excellence, strategic insight, and executional strength make them an invaluable partner for any company pursuing high-stakes regulatory approvals.”
David Veino, CEO
Neuros Medical
Case Study
Securing PMA Approval for Neuros Medical Through Integrated Data and Statistical Excellence
Device:
Altius Direct Electrical Nerve Stimulation System is FDA-approved to help adults living with lower limb loss who have chronic post-amputation pain, such as phantom limb pain or residual limb pain
Solution:
Avania partnered with Neuros on the development of a robust statistical analysis plan (SAP) and managed the analysis of primary endpoints, secondary endpoints, DMC review, and packaged all analysis outcomes for FDA approval
Problem:
Disperse datasets across device data, electronic patient reported outcome (ePRO) data, participant medication and pain diary data, in addition to a robust clinical dataset from follow-up visits at sites
Outcome:
Avania and Neuros held staged and iterative meetings post last patient in at the primary endpoint, partnered on study report strategy and writing, resulting in PMA approval without questions on the clinical module and absent an advisory committee meeting
Case Study
Accelerating Neuromodulation Trial Launch Through Strategic Precision
Device:
Novel, adaptive neuromodulation device
Solution:
Avania and the sponsor set out an aggressive yet realistic project plan to achieve regulatory approvals and clinical site start-up within a tight time window
Problem:
Device company under scrutiny of investors having completed recent, significant fundraising effort
Outcome:
FPI was achieved ahead of schedule in EU and the program continues to enroll on pace with the project plan, reflecting thought and careful attention to detail in the planning phase
Partner with Avania’s
Neurology Experts Today
Neurology innovation demands expertise that extends beyond trial execution. It requires a partner who understands the science, the systems, and the stakes. Avania combines specialized insight, experienced teams, and end-to-end capability to accelerate every step of your journey.